Details of the Drug | DrugMAP

General Information of Drug (ID: DMFJ1OW)

Drug Name

ADXS-NEO

Indication

Disease Entry	ICD 11	Status	REF
Colon cancer	2B90.Z	Phase 1	[1]
Colorectal cancer	2B91.Z	Phase 1	[2]
Head and neck cancer	2D42	Phase 1	[1]
Non-small-cell lung cancer	2C25.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: DBE26P

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT03265080) Expressing Personalized Tumor Antigens Study (NEO). U.S. National Institutes of Health.